Identification and analysis of the rare HLA-A/B/DRB1 allele genes of 10165 bone marrow registry donors in Shaanxi region.
10.7534/j.issn.1009-2137.2013.06.044
- Author:
Meng-Li LIU
1
;
Jun QI
2
;
Xiao-Fang WANG
2
;
Sheng LIU
2
;
Tian-Ju WANG
2
;
Li-Ping CHEN
2
Author Information
1. Blood Center of Shaanxi Province, Xi'an 710061, Shaanxi Province, China. E-mail: annmengli@aliyun.com.
2. Blood Center of Shaanxi Province, Xi'an 710061, Shaanxi Province, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Alleles;
Asian Continental Ancestry Group;
genetics;
Bone Marrow;
Female;
Gene Frequency;
HLA-A Antigens;
genetics;
HLA-B Antigens;
genetics;
HLA-DRB1 Chains;
genetics;
Haplotypes;
Humans;
Male;
Middle Aged;
Registries;
Tissue Donors;
Young Adult
- From:
Journal of Experimental Hematology
2013;21(6):1602-1605
- CountryChina
- Language:Chinese
-
Abstract:
This study was purposed to analyze the detected status of rare alleles from HLA-A/B/DRB1 typing of 10165 unrelated hematopoietic stem cell donors in Shaanxi region during 2009-2012. The rare allele distributions of HLA-A/B/DRB1 gene typing of 10165 unrelated-donors from Shaanxi sub-registry of Chinese National Marrow Donor Project (CMDP) were detected and analyzed by PCR-SBT. The results showed that there were 40 rare alleles from 48 donors identified by PCR-SBT in 10165 unrelated-donors of Shaanxi sub-registry. Among them, 10 rare alleles of A*02:04, B*07:10, B*27:09, B*35:11, B*44:29, DRB1*03:04, DRB1*08:18, DRB1*13:05, DRB1*13:14 and DRB1*14:11 from 15 donors were not included in the common alleles and well documented alleles (CWD) of China, but were included in the CWD of American Society for Histocompatibility and Immunogenetics (ASHI). The alleles of A*68:24, B*35:11, B*44:29, DRB1*03:04, DRB1*08:18 and DRB1*13:05 were confirmed in more than two samples. There were totally 21 novel HLA alleles identified by our laboratory and officially assigned by the WHO Nomenclature Committee from 2005 to 2012, and some of them were also detected from multiple donors in other HLA typing laboratories of China. Now the novel alleles of HLA-A*02:90, HLA-B*48:14 and HLA-DRB1*01:14 were added into the Chinese CWD list. It is concluded that to ensure the polymorphism integrity and accurate population distribution of HLA genes and its constant accumulations on CMDP, it is necessary to recognize and submit timely the potential novel alleles in our practical work, as well as to record and statistics the identified rare alleles, which can provide the basis for the modification of Chinese CWD. When CWD list is referred, it should be careful for ambiguous results containing the identified rare alleles in order to avoid the occurrence of false or undiscovered detection, and ensure that the patients carrying rare alleles could find a matching donor with the maximum opportunity.
